Technical Analysis for HEM - Hemostemix Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.060 | 0.00% | 0.000 |
HEM closed unchanged on Friday, October 11, 2024, on 3.11 times normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| 50 DMA Resistance | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 200 DMA Resistance | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 1 day ago |
| Rose Above 50 DMA | 1 day ago |
| Up 1 ATR | 1 day ago |
| Rose Above 200 DMA | 1 day ago |
| 3x Volume Pace | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2024-08-26
Hemostemix Inc is a Canada-based clinical-stage biotechnology company. The Company's principal business is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions, including critical limb ischemia (CLI). The Company's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of CLI. ACP-01 is in a Phase II clinical trial in Canada, South Africa and the United States. The Company also focuses on developing other cell products, such as bone cell precursors (BCPs), myocardial cell precursors (MCPs) and neural cell precursors (NCPs). It operates in Canada and Israel. The Company has approximately 2,200 square foot research and manufacturing facility in Ness Ziona, Israel. Hemostemix Limited is the subsidiary of the Company.
Sector: Healthcare
Industry: Biotechnology
Keywords: Manufacturing Nature Clinic Biotechnology Therapy Biology Clinical Trial Bone Hypertension Cell Biology Stem Cells Cell Products Cell Therapy Manufacturing Facility
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Manufacturing Nature Clinic Biotechnology Therapy Biology Clinical Trial Bone Hypertension Cell Biology Stem Cells Cell Products Cell Therapy Manufacturing Facility
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.13 |
| 52 Week Low | 0.035 |
| Average Volume | 193,459 |
| 200-Day Moving Average | 0.064 |
| 50-Day Moving Average | 0.068 |
| 20-Day Moving Average | 0.084 |
| 10-Day Moving Average | 0.075 |
| Average True Range | 0.009 |
| RSI (14) | 40.48 |
| ADX | 20.78 |
| +DI | 34.502 |
| -DI | 27.414 |
| Chandelier Exit (Long, 3 ATRs) | 0.077 |
| Chandelier Exit (Short, 3 ATRs) | 0.088 |
| Upper Bollinger Bands | 0.113 |
| Lower Bollinger Band | 0.054 |
| Percent B (%b) | 0.1 |
| BandWidth | 71.138 |
| MACD Line | -0.003 |
| MACD Signal Line | 0.002 |
| MACD Histogram | -0.0051 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.083 | ||||
| Resistance 3 (R3) | 0.085 | 0.080 | 0.079 | ||
| Resistance 2 (R2) | 0.080 | 0.074 | 0.079 | 0.077 | |
| Resistance 1 (R1) | 0.070 | 0.071 | 0.068 | 0.068 | 0.076 |
| Pivot Point | 0.065 | 0.065 | 0.064 | 0.064 | 0.065 |
| Support 1 (S1) | 0.055 | 0.059 | 0.053 | 0.053 | 0.044 |
| Support 2 (S2) | 0.050 | 0.056 | 0.049 | 0.043 | |
| Support 3 (S3) | 0.040 | 0.050 | 0.041 | ||
| Support 4 (S4) | 0.038 |
